IBMD Research Week public lectures
Speakers Rita Strack from Nature Methods and David Weitz from Harvard University.
IBMD or the Institute for Biomedical Materials and Devices is a UTS initiative that brings together a multidisciplinary team to "create innovative technology solutions that are designed to meet the critical unmet needs of the biomedical sector."
To drive advancement we believe in the open exchange of ideas and expertise. As such we invite you to join us for 2 public lectures as part of IBMD Research Week.
Lecture 1: Monday 17 February 2020 @ 10:30 am
Rita Strack, Editor, Nature Methods
Rita Strack is a senior editor at Nature Methods, where she handles papers covering imaging, microscopy, RNA biology, and biochemistry. She did her PhD at the University of Chicago, where she studied and engineered improved variants of the red fluorescent protein DsRed. She then did her postdoctoral work at Weill Cornell, where she developed aptamer-based fluorescent tools for studying RNA dynamics in living cells. Rita has been and with Nature Methods since November of 2014.
Lecture 2: Tuesday 18 Feb 2020 @ 9:00 am
Professor David Weitz: Harvard University
Dave Weitz is the Mallinckrodt Professor of Physics and Applied Physics at Harvard. He is also Director of Materials Research Science and Engineering Center and the Co-Director of the BASF Advanced Research Initiative. The Weitz group has interests ranging from fundamental physics to technological applications and from basic materials questions to specific biological problems. By applying technological advances in physics and materials the Weitz group has created a suite of microfluidic devices and approaches to enable high-throughput, high sensitivity, low volume assays to allow a deeper understanding of biological processes and to selectively sort cells for further analysis. In Cytometry circles, Dave is perhaps best known as the father of modern droplet-based cytometry techniques. In 2015 his work in single-cell genomics culminated in the publication of the seminal articles involving DropSeq, inDrops, Hi-SCL and Single-cell ChIP-seq.
Dave has an outstanding publication record with 105,459 citations with a h-index of 169 but also works extensively with industry. Dave has an enviable commercialization track record with numerous patents and research within the group routinely leading to promising new technologies and giving rise to start-up companies.
The Institute for Biomedical Materials & Devices (IBMD) is a newly created institute at UTS Faculty of Science which aims to transform advances in photonics and materials into revolutionary biomedical technologies. IBMD Research Week brings together the best of brains in the research area, provides unique opportunity to discuss the progress in photonics, material science, nanotechnology, and enhances the collaboration between the researchers in Asia-Pacific Economic Cooperation (APEC) countries.